Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of PYLERA™ (Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride) With Omeprazole Given x 10 Days in Subjects Who Failed Treatment for Eradication of Helicobacter pylori [Efficacia e sicurezza della somministrazione di PYLERA` (bismuto subcitrato potassio, metronidazolo e tetraciclina cloridrato) con omeprazolo per un periodo di 10 giorni in soggetti refrattari a trattamenti di eradicazione dell'Helicobacter pylori].

Next Previous
X
Search
Trial Profile

Efficacy and Safety of PYLERA™ (Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride) With Omeprazole Given x 10 Days in Subjects Who Failed Treatment for Eradication of Helicobacter pylori [Efficacia e sicurezza della somministrazione di PYLERA` (bismuto subcitrato potassio, metronidazolo e tetraciclina cloridrato) con omeprazolo per un periodo di 10 giorni in soggetti refrattari a trattamenti di eradicazione dell'Helicobacter pylori].

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary) ; Omeprazole
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Sponsors Adare Pharmaceuticals

    • Most Recent Events

    • 07 Oct 2021 This trial is completed in spain (global end of the trial 2013-01-18) as reported by European Clinical Trials Database record.
    • 19 May 2012 Planned number of patients changed from 12 to 50 as reported by European Clinical Trials Database.
    • 19 May 2012 Company added in association field as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top